The study was a dose-ranging, 18-week study comparing two doses of HTD1801 (500 mg BID and 1000 mg BID) to placebo in adult subjects with PSC.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Absolute Change in Serum Alkaline Phosphatase (ALP) From Baseline to Week 6 in Period 1
Timeframe: Baseline to Week 6